4893.T
Price:
$161
Market Cap:
$6.97B
Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.
Industry
Biotechnology
IPO Date
2023-06-28
Stock Exchange
JPX
Ticker
4893.T
According to Noile-Immune Biotech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -10.06. This represents a change of -20.06% compared to the average of -12.58 of the last 4 quarters.
The mean historical PE Ratio of Noile-Immune Biotech Inc. over the last ten years is -34.20. The current -10.06 PE Ratio has changed 2.84% with respect to the historical average. Over the past ten years (40 quarters), 4893.T's PE Ratio was at its highest in in the March 2024 quarter at -6.01. The PE Ratio was at its lowest in in the September 2023 quarter at -284.09.
Average
-34.20
Median
-36.98
Minimum
-72.44
Maximum
-7.63
Discovering the peaks and valleys of Noile-Immune Biotech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 95.88%
Maximum Annual PE Ratio = -7.63
Minimum Annual Increase = -89.26%
Minimum Annual PE Ratio = -72.44
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -7.63 | -1.90% |
| 2023 | -7.78 | -89.26% |
| 2022 | -72.44 | 95.88% |
| 2021 | -36.98 | -19.92% |
The current PE Ratio of Noile-Immune Biotech Inc. (4893.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-29.28
5-year avg
-34.20
10-year avg
-34.20
Noile-Immune Biotech Inc.’s PE Ratio is less than TMS Co., Ltd. (-8.13), less than K Pharma,Inc. (-8.59), less than BrightPath Biotherapeutics Co., Ltd. (-4.40), less than OncoTherapy Science, Inc. (-7.06), less than ADR120S, Inc. (-4.07), greater than Linical Co., Ltd. (-10.76), less than PRISM BioLab Co.,LTD (-5.06), less than MedRx Co., Ltd (-4.39), less than Chiome Bioscience Inc. (-7.56), less than Kohjin Bio Co., Ltd. (11.15),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.13 | $6.10B | |
| -8.59 | $7.43B | |
| -4.40 | $4.63B | |
| -7.06 | $7.11B | |
| -4.07 | $7.44B | |
| -10.76 | $6.82B | |
| -5.06 | $6.51B | |
| -4.39 | $6.53B | |
| -7.56 | $7.55B | |
| 11.15 | $7.96B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Noile-Immune Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Noile-Immune Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Noile-Immune Biotech Inc.'s PE Ratio?
How is the PE Ratio calculated for Noile-Immune Biotech Inc. (4893.T)?
What is the highest PE Ratio for Noile-Immune Biotech Inc. (4893.T)?
What is the 3-year average PE Ratio for Noile-Immune Biotech Inc. (4893.T)?
What is the 5-year average PE Ratio for Noile-Immune Biotech Inc. (4893.T)?
How does the current PE Ratio for Noile-Immune Biotech Inc. (4893.T) compare to its historical average?